Correction to “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutophagy in Disease and Therapy · COVID-19 Clinical Research Studies · Adipokines, Inflammation, and Metabolic Diseases
W. Bai, H. Wang, C. Gao, et al., “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy,” Oxidative Medicine and Cellular Longevity 2021 (2021): 2860488, https://doi.org/10.1155/2021/2860488.
In the article titled, “Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy,” there was an error in Figure 1a. In Figure 1 legend, Ang IV and MI were attributed to the wrong color. The corrected figure is shown below and is listed as Figure 1:
We apologize for this error.